Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Limiting the risk of immunogenicity by identification and removal of T-cell epitopes (DeImmunisation™)

K Hellendoorn email, T Jones, J Watkins, M Baker, A Hamilton and F Carr

from Association for Immunotherapy of Cancer: Cancer Immunotherapy – 2nd Annual Meeting
Mainz, Germany. 6–7 May 2004

Cancer Cell International 2004, 4(Suppl 1):S20doi:10.1186/1475-2867-4-S1-S20

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.